You are here: Industry Insights > dry AMD

News List

Paragon Biosciences Expands Cell and Gene Therapy Platform contractpharma
February 09, 2021
Paragon Biosciences, a life science innovator that creates, invests in and builds life science companies in biopharmaceuticals, cell and gene therapy and synthetic biology utilizing artificial intelligence, has launched CiRC Biosciences ...
Belite Bio Announces Positive Results from LBS-008 Trial for Dry AMD, Stargardt Disease americanpharmaceuticalreview
July 27, 2020
Belite Bio announced positive results from two Phase 1 clinical trials in the United States and Australia for LBS-008, a First-in-Class oral small molecule Retinol Binding Protein 4 (RBP4) specific antagonist aimed to treat atrophic Age-related ...
Catalyst Biosciences Announces Global License, Collaboration Agreement americanpharmaceuticalreview
December 24, 2019
Catalyst Biosciences has entered into a global license and collaboration agreement with Biogen for the development and commercialization of pegylated CB 2782 (CB 2782-PEG) ...